NCT05702229 2026-03-18
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
Phase 2 Recruiting
Clinical Trials
89 trialsNCT07468630 2026-03-12
TRIUNITE-08
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Recruiting
NCT07453875 2026-03-06
TRIUNITE06
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 1 Not yet recruiting
NCT07448142 2026-03-04
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT06346197 2026-03-02
CIME
Centre Leon Berard
Phase 3 Recruiting
NCT04495088 2026-02-02
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Universitätsmedizin Mannheim
Phase 3 Recruiting
NCT07381777 2026-02-02
IMMUNOSTAR
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2 Not yet recruiting
NCT07334431 2026-01-12
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT07229846 2026-01-08
A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation
Harbin Medical University
Phase 2 Not yet recruiting
NCT07127497 2025-11-21
Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
The First Affiliated Hospital of Anhui Medical University
Phase 2 Active not recruiting
NCT07007182 2025-09-05
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Shandong Cancer Hospital and Institute
Phase 2 Not yet recruiting
NCT07156682 2025-09-05
QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer
Qilu Hospital of Shandong University
Phase 2 Not yet recruiting
NCT07132463 2025-08-20
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
Fudan University
Phase 3 Not yet recruiting
NCT07108127 2025-08-06
NePHera
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT07068516 2025-07-16
Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer
Zhejiang Cancer Hospital
Phase 3 Not yet recruiting
NCT06848465 2025-05-11
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 1 Recruiting
NCT01643070 2025-02-25
Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases
Asan Medical Center
Phase 2 Completed
NCT04380337 2025-02-25
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer
Stanford University
Phase 2 Completed
NCT03662659 2025-02-05
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
Bristol-Myers Squibb
Phase 2 Completed
NCT06475352 2025-01-27
FUDOSE
UNICANCER
Phase 2 Recruiting
NCT06128252 2025-01-07
Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
Tang-Du Hospital
Phase NA Recruiting
NCT03565029 2024-12-27
NO-CUT
Niguarda Hospital
Phase 2 Completed
NCT01531595 2024-12-12
AXOAXI
Helsinki University Central Hospital
Phase 2 Active not recruiting
NCT06242418 2024-12-12
REVISE
West China Hospital
Phase 2 Recruiting
NCT06650332 2024-10-21
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Zhejiang Cancer Hospital
Phase 1/2 Recruiting
NCT05086627 2024-08-22
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital
Phase 2 Completed
NCT02355379 2024-07-08
ADAGE
Federation Francophone de Cancerologie Digestive
Phase 3 Recruiting
NCT03714490 2024-05-29
SUNRISE
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT06023758 2024-05-10
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Peking University
Phase 2 Recruiting
NCT05228431 2024-04-22
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT04543695 2024-03-26
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT01910610 2024-03-12
STRATEGIC-1
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Active not recruiting
NCT06227325 2024-01-26
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Phase 2 Unknown
NCT05494060 2023-11-07
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT06115174 2023-11-02
CRC - PTX
Tanta University
Phase 4 Unknown
NCT03840239 2023-10-25
TESS
Sun Yat-sen University
Phase 2 Active not recruiting
NCT00958737 2023-09-29
IDEA
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Unknown
NCT05264896 2023-09-07
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Chinese University of Hong Kong
Phase 3 Recruiting
NCT05985707 2023-08-21
KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT04659382 2023-08-18
SIRTCI
Federation Francophone de Cancerologie Digestive
Phase 2 Unknown
NCT05969847 2023-08-01
TRACE-LE
Fujian Medical University Union Hospital
Phase 2 Not yet recruiting
NCT05715632 2023-07-14
New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
Tang-Du Hospital
Phase NA Unknown
NCT05420584 2023-05-11
NECI
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 2 Unknown
NCT04744649 2022-11-15
NICE
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT05545436 2022-09-22
Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown
NCT05468138 2022-08-26
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
Fudan University
Phase 2 Unknown
NCT03666442 2022-04-29
Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer
West China Hospital
Phase 2 Completed
NCT03957733 2022-04-06
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
King Abdullah Medical City
Phase 2/3 Unknown
NCT05193292 2022-01-14
Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT04418895 2021-11-10
Neoadjuvant Therapy for Localized Rectal Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
Phase 2 Withdrawn